Exhibit 99.1

LifePoint Hospitals Reports Fourth Quarter and Year-End 2014 Results

Fourth Quarter Revenues Increased 33% Year Over Year to $1.26 Billion

Company Issues 2015 Guidance

BRENTWOOD, Tenn.--(BUSINESS WIRE)--February 12, 2015--LifePoint Hospitals, Inc. (NASDAQ: LPNT) today announced results for the fourth quarter and year ended December 31, 2014.

For the fourth quarter ended December 31, 2014, revenues from continuing operations were $1,262.9 million, up 32.6% from $952.6 million for the same period a year ago. Adjusted EBITDA for the fourth quarter ended December 31, 2014, increased 17.2% to $174.0 million compared with $148.5 million for the same period a year ago. Adjusted EBITDA for the fourth quarter ended December 31, 2014, excludes an impairment charge of $45.5 million, or $0.60 per diluted share, for the write down of property, equipment, allocated goodwill and certain other assets in connection with the sale of three hospitals in Alabama. Including the impairment charge, income from continuing operations attributable to LifePoint Hospitals, Inc. stockholders decreased 37.5% to $22.4 million, or $0.48 per diluted share, compared with $35.9 million, or $0.75 per diluted share, for the same period a year ago.

For the year ended December 31, 2014, revenues from continuing operations were $4,483.1 million, up 21.9% from $3,678.3 million for the same period a year ago. Adjusted EBITDA for 2014 increased 18.1% to $634.2 million compared with $537.0 million for the same period a year ago. Adjusted EBITDA for 2014 excludes impairment charges of $57.7 million, or $0.76 per diluted share. Including the impairment charges, income from continuing operations attributable to LifePoint Hospitals, Inc. stockholders decreased 1.3% to $126.1 million, or $2.69 per diluted share, compared with $127.8 million, or $2.68 per diluted share, for the same period a year ago.

“We concluded 2014 with another quarter of solid financial performance,” said William F. Carpenter III, chairman and chief executive officer of LifePoint Hospitals. “Our differentiated strategy makes us the partner of choice for many community hospitals and is delivering strong results. In addition, we continue to develop talent, effectively manage costs and focus on quality and patient safety. These initiatives, together with our ability to capture the benefits of healthcare reform, position us well for 2015. We thank LifePoint’s talented employees and physicians, who provide our patients with high-quality care every day.”

The Company also issued the following guidance for 2015:

Guidance for 2015 includes the estimated receipt of $44.0 million of meaningful use funds, a $7.0 million increase from healthcare reform over 2014, and an increase in blended net revenue per equivalent admission of 0.5% to 2.5%, but does not include the impact of items, if applicable, that are non-operational in nature, including items such as, but not limited to, gains or losses on sales of hospitals and businesses, share repurchases (if any), gains or losses on early debt retirement, impairments of long-lived assets or hospital acquisitions completed in 2015. Depreciation expense for 2015 is expected to increase by approximately $30.0 million and interest expense is expected to decline by approximately $6.0 million. This guidance is also subject to certain risks, including those as set forth in the Company’s “Important Legal Information.”

A listen-only simulcast, as well as a 30-day replay, of LifePoint Hospitals’ fourth quarter and year-end 2014 conference call will be available on line at www.lifepointhospitals.com/news/press-releases today, Thursday, February 12, 2015, beginning at 10:00 a.m. Eastern Time.

LifePoint Hospitals, Inc. is a leading hospital company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates 65 hospital campuses in 21 states. With a mission of “Making Communities Healthier®,” LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, www.LifePointHospitals.com. All references to “LifePoint,” “LifePoint Hospitals,” or the “Company” used in this release refer to LifePoint Hospitals, Inc. or its affiliates.

Important Legal Information. Certain statements contained in this release, including LifePoint’s guidance for the year ended December 31, 2015, are based on current management expectations and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to qualify for the safe harbor protections from liability provided by the Private Securities Litigation Reform Act of 1995. Numerous factors exist which may cause results to differ from these expectations. Many of the factors that will determine our future results are beyond our ability to control or predict with accuracy. Such forward-looking statements reflect the current expectations and beliefs of the management of LifePoint, are not guarantees of performance and are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ from those described in the forward-looking statements. These forward-looking statements may also be subject to other risk factors and uncertainties, including without limitation: (i) the effects related to the enactment and implementation of healthcare reform, the possible enactment of additional federal or state healthcare reforms and possible changes in healthcare reform laws and other federal, state or local laws or regulations affecting the healthcare industry including the timing of the implementation of reform; (ii) the extent to which states support increases, decreases or changes in Medicaid programs, implement healthcare exchanges or alter the provision of healthcare to state residents through regulation or otherwise; (iii) delays in receiving payments for services provided, reductions in Medicare or Medicaid payments (including increased recoveries made by Recovery Audit Contractors (RAC) and similar governmental agents), compared to the timing of expanded coverage; (iv) reductions in reimbursements from commercial payors; (v) our ability to acquire hospitals and other healthcare providers on favorable terms, the business risks and costs associated therewith and the uncertainty in operating and integrating such hospitals and other providers; (vi) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments; (vii) the deterioration in the collectability of “bad debt” and “patient due” accounts, the number of individuals without insurance coverage (or who are underinsured) who seek care at our hospitals; (viii) whether our core strategies will result in anticipated operating results, including measurable quality and satisfaction improvements; (ix) whether our efforts to reduce the cost of providing healthcare while increasing the quality of care are successful; (x) the ability to attract, recruit or employ and retain qualified physicians, nurses, medical technicians and other healthcare professionals and the increasing costs associated with doing so, including the direct and indirect costs associated with employing physicians and other healthcare professionals; (xi) the loss of certain physicians in markets where such a loss can have a disproportionate impact on our hospital in such market; (xii) the application, interpretation and enforcement of increasingly stringent and complex laws and regulations governing our operations and healthcare generally (and changing interpretations of applicable laws and regulations), related enforcement activity and the potentially adverse impact of known and unknown government investigations, litigation and other claims that may be made against us; (xiii) any interruption of or restriction in our prompt access to licensed or owned information (and information technology systems) or failure in our ability to integrate changes to LifePoint’s existing information systems or information systems of acquired hospitals; (xiv) adverse events in states where a large portion of our revenues are concentrated; (xv) liabilities resulting from potential malpractice and related legal claims brought against our hospitals or the healthcare providers associated with, or employed by, such hospitals or affiliated entities; (xvi) our increased dependence on third parties to provide purchasing, revenue cycle and payroll services and information technology and whether they are able to do so effectively; (xvii) the continued viability of our operations through joint venture entities, the largest of which is Duke LifePoint Healthcare, our partnership with a wholly controlled affiliate of Duke University Health Systems, Inc.; and (xviii) those other risks and uncertainties described from time to time in our filings with the Securities and Exchange Commission. Therefore, our future results may differ materially from those described in this release. LifePoint undertakes no obligation to update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

All references to “our,” “LifePoint,” “LifePoint Hospitals” and the “Company” as used throughout this release refer to LifePoint Hospitals, Inc. and its subsidiaries.

⁽¹⁾ Continuing operations information includes the results of our hospital support center, our same-hospital operations and the results of our recent acquisitions completed in 2014 and 2013. Additionally, continuing operations information includes the results of River Parishes Hospital, which was sold effective November 1, 2014, and Lakeland Community Hospital, Northwest Medical Center and Russellville Hospital, which were sold effective January 1, 2015.

⁽²⁾ Management and investors use equivalent admissions as a general measure of combined inpatient and outpatient volume. We compute equivalent admissions by multiplying admissions (inpatient volumes) by the outpatient factor (the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue). The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume.

⁽³⁾ Same-hospital information includes the results of our hospital support center and the same 53 hospitals operated during the years ended December 31, 2014 and 2013. Same-hospital information excludes the results of our recent acquisitions completed in 2014 and 2013, with the exception of Scott Memorial Hospital, which we acquired effective January 1, 2013, through our joint venture with Norton Healthcare, Inc. and which is included in our same-hospital information. Additionally, same-hospital information excludes our hospitals that have previously been disposed, in addition to Lakeland Community Hospital, Northwest Medical Center and Russellville Hospital, which were sold effective January 1, 2015.

LIFEPOINT HOSPITALS, INC.
UNAUDITED SUPPLEMENTAL INFORMATION
Dollars in millions, except Diluted EPS amounts

Adjusted EBITDA is defined by the Company as earnings before depreciation and amortization; interest expense, net; impairment charges; debt transaction costs; gain on settlement of pre-acquisition contingent obligation; provision for income taxes; loss (income) from discontinued operations, net of income taxes; and net income attributable to noncontrolling interests and redeemable noncontrolling interests. LifePoint’s management and Board of Directors use Adjusted EBITDA to evaluate the Company’s operating performance and as a measure of performance for incentive compensation purposes. LifePoint’s credit facilities use Adjusted EBITDA, subject to further permitted adjustments, for certain financial covenants. The Company believes Adjusted EBITDA is a measure of performance used by some investors, equity analysts and others to make informed investment decisions. In addition, multiples of current or projected Adjusted EBITDA are used to estimate current or prospective enterprise value. Adjusted EBITDA should not be considered as a measure of financial performance under U.S. generally accepted accounting principles (“GAAP”), and the items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the condensed consolidated financial statements as an indicator of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies.

The following table reconciles Adjusted EBITDA as presented above to net income attributable to LifePoint Hospitals, Inc. as reflected in the unaudited condensed consolidated statements of operations:

CONTACT:
LifePoint Hospitals, Inc.
Leif Murphy, 615-920-7664
Executive Vice President and
Chief Financial Officer